Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
PPLPHARMA

Piramal Pharma Share Price

 

 

Piramal Pharma live price: ₹179.46. It opened at ₹176 vs previous close ₹176; intraday high/low: ₹181/₹175. The 50 & 200 DMA stand at ₹163.71/₹173.27.

Piramal Pharma Performance

  • Today's Low
  • ₹175
  • Today's High
  • ₹181
  • 52 Week Low
  • ₹132
  • 52 Week High
  • ₹221
  • Open Price₹176
  • Previous Close₹176
  • Volume2,936,240
  • 50 DMA₹163.71
  • 100 DMA₹164.50
  • 200 DMA₹173.27

Piramal Pharma Chart

Investment Returns

  • Over 1 Month + 8.45%
  • Over 3 Month + 12.53%
  • Over 6 Month -3.69%
  • Over 1 Year -12.6%

Smart Investing Starts Here Start SIP with Piramal Pharma for Steady Growth!

Invest Now

Piramal Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -73.2
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 23,855
  • P/B Ratio
  • 3
  • Average True Range
  • 6.85
  • EPS
  • 0
  • Dividend Yield
  • 0.1
  • MACD Signal
  • 6.29
  • RSI
  • 64.2
  • MFI
  • 71.74

Latest Stock News Updates

Piramal Pharma Solutions Unveils State-of-the-Art Payload-Linker Suite at its Riverview, Michigan Facility

Piramal Pharma Limited Announces Results for Q4 and Full-year FY26

Piramal Pharma expects FY 2027 to see a revival in growth

It posted a Rs 9 crore loss Q4 FY 26, impacted by an impairment cost of Rs 176 crore linked to assets under development

Piramal Pharma Financials

Piramal Pharma Technicals

EMA & SMA

Current Price
₹179.46
+ 3.83 (2.18%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹171.35
  • 50 Day
  • ₹163.71
  • 100 Day
  • ₹164.50
  • 200 Day
  • ₹173.27

Resistance and Support

178.47 Pivot Speed
  • R3 187.14
  • R2 183.92
  • R1 181.69
  • S1 176.24
  • S2 173.02
  • S3 170.79

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Piramal Pharma Ltd. provides pharmaceutical solutions, including contract manufacturing, active pharmaceutical ingredients (APIs), and consumer healthcare products. It serves global markets, offering high-quality healthcare products to pharmaceutical companies and end consumers.

Piramal Pharma has an operating revenue of Rs. 8,869.07 Cr. on a trailing 12-month basis. An annual revenue de-growth of -2% needs improvement, Pre-tax margin of -3% needs improvement, ROE of -3% is poor and needs improvement. The company has a debt to equity of 53%, which is bit higher. The stock from a technical standpoint is trading close to its 200DMA and around 12% above its 50DMA. It needs to stay above the 200DMA levels to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 5 which is a POOR score indicating inconsistency in earnings, a RS Rating of 57 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 60 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Piramal Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-04-28 Audited Results
2026-01-28 Quarterly Results
2025-11-05 Quarterly Results
2025-07-28 Quarterly Results
2025-05-14 Audited Results & Final Dividend
Date Purpose Remarks
2025-07-16 FINAL Rs.0.14 per share(1.4%)Final Dividend
2024-07-12 FINAL Rs.0.11 per share(1.1%)Final Dividend
View Piramal Pharma Dividend History Arrow

Piramal Pharma Shareholding Pattern

34.86%
14.12%
1.24%
12.22%
0%
13.74%
23.82%

Piramal Pharma FAQs

Piramal Pharma share price is ₹179 As on 26 May, 2026 | 01:31

The Market Cap of Piramal Pharma is ₹23854.7 Cr As on 26 May, 2026 | 01:31

The P/E ratio of Piramal Pharma is -73.2 As on 26 May, 2026 | 01:31

The PB ratio of Piramal Pharma is 3 As on 26 May, 2026 | 01:31

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23